Concordance between independent first‐line assessors in the Western Australian Audit of Surgical Mortality

2021 ◽  
Author(s):  
Franca Itotoh ◽  
Natalie Zorbas ◽  
Andrew Lukman ◽  
R James Aitken
Keyword(s):  
Surgical Mortality ◽  
First Line ◽  
Western Australian

PROVIDERS AND CONSUMERS SUPPORT THE WESTERN AUSTRALIAN AUDIT OF SURGICAL MORTALITY

2006 ◽  
Vol 76 (6) ◽  
pp. 442-447 ◽  
Author(s):  
James B. Semmens ◽  
Jenny A. Mountain ◽  
Frank M. Sanfilippo ◽  
Jenny Y. Barraclough ◽  
Anne McKenzie ◽  
...  
Keyword(s):  
Surgical Mortality ◽  
Western Australian

The Western Australian Audit of Surgical Mortality: advancing surgical accountability

2005 ◽  
Vol 183 (10) ◽  
pp. 504-508 ◽  
Author(s):  
James B Semmens ◽  
Frank M Sanfilippo ◽  
S Aqif Mukhtar ◽  
Natasha S Haynes ◽  
Jenny A Mountain ◽  
...  
Keyword(s):  
Surgical Mortality ◽  
Western Australian

scholarly journals The Western Australian Audit of Surgical Mortality: outcomes from the first 10 years

2013 ◽  
Vol 199 (8) ◽  
pp. 539-542 ◽  
Author(s):  
Diana G Azzam ◽  
C Adeline Neo ◽  
Franca E Itotoh ◽  
R James Aitken
Keyword(s):  
Surgical Mortality ◽  
Western Australian

scholarly journals Managing migraine with over-the-counter provision of triptans: the perspectives and readiness of Western Australian community pharmacists

PeerJ ◽  
2019 ◽  
Vol 7 ◽  
pp. e8134
Author(s):  
Shaid Booth ◽  
Richard Parsons ◽  
Bruce Sunderland ◽  
Tin Fei Sim
Keyword(s):  
Community Pharmacists ◽  
Multivariate Regression Analysis ◽  
Warning Signs ◽  
Migraine Treatment ◽  
First Line ◽  
Over The Counter ◽  
Implementation Model ◽  
Timely Access ◽  
Current Guidelines ◽  
Western Australian

Background Down-scheduling one or more triptans to Schedule 3 (Pharmacist Only Medicine) from Schedule 4 (Prescription Only Medicine) has been debated in Australia for a decade. This study aimed to evaluate the perspectives and readiness of Western Australian (WA) community pharmacists to manage migraine including over-the-counter (OTC) provision of triptans. Methods Data were collected using a self-administered paper-based questionnaire, posted to a random sample of 178 metropolitan and 97 regional pharmacies in WA. Respondent pharmacists were surveyed regarding: knowledge of optimal migraine treatment as per current guidelines, resources required to appropriately recommend triptans and attitudes and perspective toward down-scheduling. Data were analysed using descriptive statistics and multivariate regression analysis. Pharmacist/pharmacy characteristics influencing readiness were evaluated by assigning respondents a score based on responses to Likert scale questions. These questions were assigned to five domains based on an implementation model and these scores were used in a general linear model to identify demographic characteristics associated with readiness across each domain. Results A total of 114 of the 275 pharmacies returned useable questionnaires (response rate: 41.5%). The two most commonly recommended first line OTC agents were a combined paracetamol/non-steroidal anti-inflammatory drugs and aspirin (44/104; 42.3% and 22/104; 21.2%, respectively) which provided context to the respondents’ knowledge of optimal migraine treatment. Responses to questions in relation to triptans and the warning signs requiring referral were in line with current guidelines, demonstrating respondents’ knowledge in these areas. Nevertheless, most respondents demonstrated uncertainty in relation to the pathogenesis of migraine. If triptans were available OTC, 66/107 (61.7%) would recommend them first-line. The majority (107/113; 94.7%) agreed that down-scheduling would improve timely access to effective migraine medication and 105/113 (92.9%) agreed that if triptans were down-scheduled, pharmacists may be better able to assist people in the treatment of migraine. Most respondents agreed that additional training and resources, including a guideline for OTC supply of triptans and the management of first-time and repeat migraine would be necessary if triptans were down-scheduled. No single demographic characteristic influenced readiness across all five domains. Discussion Pharmacists were knowledgeable regarding triptans and recognised symptoms requiring referral; migraine knowledge could be improved. Pharmacists supported down-scheduling of one or more triptans in Australia, however they highlighted a need for further training and resources to support migraine diagnosis and provision of OTC triptans. Professional pharmacy bodies should consider these findings when recommending drugs suitable for down-scheduling for pharmacist recommendation.

1664: Androgen Metabolism Genotypes as Predictors of PSA Progression and First line Hormonal Deprivation Failure

2004 ◽  
Vol 171 (4S) ◽  
pp. 440-440
Author(s):  
Fernando J. Bianco ◽  
Mark B. Fisher ◽  
Michael L. Cher ◽  
Richard Everson ◽  
Wael A. Sakr ◽  
...  
Keyword(s):  
First Line ◽  
Androgen Metabolism ◽  
Psa Progression

1904: Outcomes of Large Renal Calculi (>2-Cm) Treated with ESWL as First Line Therapy

2004 ◽  
Vol 171 (4S) ◽  
pp. 503-503
Author(s):  
Richard Vanlangendock ◽  
Ramakrishna Venkatesh ◽  
Jamil Rehman ◽  
Chandra P. Sundaram ◽  
Jaime Landman
Keyword(s):  
Renal Calculi ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

First-Line Methotrexate Upheld by Euro Panel

2009 ◽  
Vol 40 (9) ◽  
pp. 32
Author(s):  
MITCHEL L. ZOLER
Keyword(s):  
First Line
Sign in / Sign up

Export Citation Format

Share Document